Biology

Sort by: title, date.

Arcadia Science: A New Institutional Model for the Research and Translation of Biological Discovery
Jan/20 Thu 12:00PM–01:30PM

Dr. Prachee Avasthi, PhD, Arcadia Science, Co-founder, Chief Scientific Officer, and Director of Cell Biology, Geisel School of Medicine at Dartmouth, Associate Professor of Biochemistry and Cell Biology

Arcadia Science is a new for-profit research institute distinct from traditional academic and biotech environments. Their mission is to uncover novel biology of non-model organisms and to directly commercialize impactful discoveries. Composed of scientists, engineers, and entrepreneurs, Arcadia Science is creating a unique environment to empower curiosity-driven discoveries that are also financially self-sustaining. Join us for this moderated Q&A with their Co-Founder and Chief Scientific Officer, Dr. Prachee Avasthi, to learn more about Arcadia Science.

Session organizers: Chris Giuliano and Alex Chan

Zoom link: https://mit.zoom.us/j/96281958467

Password: MITBiology

Cancelled -- Gene Regulation and Expression Talk Series: "Single-cell Epigenomics: Gene Regulation at Unprecedented Resolution"
Jan/18 Tue 12:00PM

Dr. Jason Buenrostro, Assistant Professor at Harvard University

Gene Regulation and Expression Talk Series: "Fundamental Principles During the Egg-to-embryo Transition"
Jan/11 Tue 12:00PM–01:00PM

Dr. Andrea Pauli, Group Leader at the Research Institute of Molecular Pathology (IMP), Vienna

How to Carve Your Path in the Biopharmaceutical Industry
Jan/10 Mon 03:00PM–05:00PM

Tamara Reyes-Robles, PhD, Associate Principal Scientist, Chemical Biology, Exploratory Science, Center, Merck

Nina Leksa, PhD, Distinguished Scientist, Lab Head, Hemophilia and Musculoskeletal Disease Research Center, Sanofi

Amaris Torres Delgado, PhD, Senior Scientist, Process Development, Amgen

Cynthia Barber, PhD, Senior Director, Program Management, Vertex

Amgen, Merck, Vertex and Sanofi are multinational biopharmaceutical companies with 20,000-100,000 employees generating numerous commercially available drugs. In this session, we will chat with scientists working in each of these companies to learn about their company culture, structure, and different career paths. Join us for an engaging discussion on what it takes to succeed in biopharma and learn about the challenges and benefits of working in such well established companies.

Session organizer: Fiona Aguilar

Zoom link: https://mit.zoom.us/j/94822544788

Password: MITBiology

How to Navigate the Biotech Startup Network
Jan/28 Fri 03:00PM–05:00PM

Ohad Yosefson, PhD, Associate Director of Protein Sciences, Repertoire Immune Medicines

Nathan Young, PhD, Associate Director of Molecular and Cellular Oncology, Ikena Oncology

Megan Warner, PhD, Senior Scientist, Protein Sciences, CRISPR Therapeutics

The Boston biotech sector is booming with scientific innovation, investments, and company creation. In this session, we will chat with scientists from three different biotech companies to learn how to navigate a career in a constantly evolving company while managing expectations and responsibilities. Learn about their previous experiences and job roles and inquire about their thoughts on the biotech landscape.

Repertoire Immune Medicines is a series B funded Flagship Pioneering company seeking to rationally engineer T cell receptor (TCR)-antigen interactions. Ikena Oncology is a public company focusing on genetically defined or biomarker-driven cancer targets. CRISPR Therapeutics is a public gene editing company developing treatments for hemoglobinopathies, cancer, and diabetes. All three are clinical-stage companies at the frontline of innovation.

Session organizer: Fiona Aguilar

Tentative: hybrid mode 68-181

Otherwise, Zoom link: https://mit.zoom.us/j/95349775648

Password: MITBiology

Impact of AI in Drug Discovery
Jan/12 Wed 01:30PM–03:00PM

Dr. Pat Walters, Senior VP of Computation, Relay Therapeutics

Dr. Gevorg Grigoryan, Co-founder and Chief Technology Officer, Generate Biomedicines

Dr. Eric Ma, Principal Data Scientist, Moderna

The impact of artificial intelligence in drug discovery is becoming more apparent as more and more biopharmaceutical companies are investing heavily in it as well as news of its significant roles in new drugs abound. The flexibility of AI has made it applicable in all areas of pharmaceutical research including small molecules, protein and RNA-based therapeutics. This session will explore this impact with three of the fastest growing biotech companies that are pushing the boundaries of AI in Biology. Our speakers are leading scientific leaders from Relay Therapeutics—a leading company in AI-based small molecule drug design, Generate Biomedicines—a company invested in using AI to design protein-based drugs, and Moderna—a nearly household name that has been at the forefront of revolutionizing vaccine research with the help of AI.

Join us for a session where we learn how these three industry leaders are integrating AI and biology for faster and more effective drug discovery. They will each give a 15-minute talk about their specific research areas and the talks will be followed by an engaging panel discussion. Come learn about how you can position yourself to be part of the AI revolution!

Session organizer: Israel Desta

Wednesday, January 12th, 1:30–3:00 PM, 68-181

Hybrid for attendants, speakers are in-person

Zoom link: https://mit.zoom.us/j/98600056532

Password: MITBiology

Postponed, new date TBD -- New Positions, New Perspectives
Jan/13 Thu 03:00PM–05:00PM

Professors Olivia Corradin, Yadira Soto-Feliciano, Sinisa Hrvatin, Kristin Knouse, Hernandez Moura Silva, Sara Prescott, Francisco J. Sánchez-Rivera, Alison Ringel, and Harikesh Wong

New faculty members joining the Biology Department this year bring with them fresh perspectives on their scientific journeys, strategies for pursuing an academic career, and visions for the scientific community. Join us for a discussion of their bold ideas and followed by a facilitated reception to get to know them individually.

Session organizers: Eliezer Calo, Aditi Shukla, Alice Herneisen

Thursday, January 13th, 3:00–5:00 PM, 68-180/181

Science and Society Seminars: A Field Guide to Values in Science for Biologists
Jan/13 Thu 01:30PM

Hosted by Biology DEI Officer Hallie Dowling-Huppert and the Graduate Committee.

Staying at the Bench: Non-PI Careers that Keep You Doing the Work You Love
Jan/04 Tue 12:30PM–02:00PM

Boryana (Bory) Petrova, PhD, Instructor,Harvard Medical School

Stuart Levine, PhD, Director,BioMicro Center, MIT

Christina Steadman, PhD, Staff Scientist, Los Alamos National Laboratory

What if I want to keep doing science? Many post-PhD careers take trained scientists away from the bench, but that need not be the case. Hear about the perspectives and trajectories of three “staff scientists”—some of whom conducted postdoctoral research at MIT—and how their work overlaps and diverges from that of a PI at an academic institution.

Session organizers: Dylan McCormick and Alice Herneisen

Zoom link: https://mit.zoom.us/j/96695361761

Password: MITBiology

Staying at the Bench: Non-PI Careers that Keep You Doing the Work You Love
Jan/14 Fri 12:30PM–02:00PM

Boryana (Bory) Petrova, PhD, Instructor,Harvard Medical School

Stuart Levine, PhD, Director,BioMicro Center, MIT

Christina Steadman, PhD, Staff Scientist, Los Alamos National Laboratory

What if I want to keep doing science? Many post-PhD careers take trained scientists away from the bench, but that need not be the case. Hear about the perspectives and trajectories of three “staff scientists”—some of whom conducted postdoctoral research at MIT—and how their work overlaps and diverges from that of a PI at an academic institution.

Session organizers: Dylan McCormick and Alice Herneisen

Zoom link: https://mit.zoom.us/j/96695361761

Password: MITBiology

Using Your PhD to Combat Climate Change
Jan/26 Wed 02:00PM–03:30PM

 

Dr. Rachel Fraser, PhD, Impossible Foods, Vice President of Downstream Process Development

Dr. Hélène Berges, PhD, Inari Agriculture, Vice President of Research and Development

The climate crisis has galvanized scientists to pursue bold ideas to both reduce carbon emissions, as well as adapt to a changing environment. Join us for a moderated Q&A to discover how we, as biologists, can leverage the skills that we have acquired to pursue industry research positions that are focused on sustainability. We will be speaking to Dr. Rachel Fraser, the Vice President of Downstream Process Development at Impossible Foods, a company focused on developing plant-based meat substitutes, and Dr. Hélène Berges, Vice President of Research and Development at Inari Agriculture, a company harnessing AI and multiplexed gene editing to produce robust seeds for food production.

Session organizers: Alex Chan and Aditi Shukla

Zoom link: https://mit.zoom.us/j/98725240323

Password: MITBiology